Systematic Assessment of the Adsorption of 99mTc-Radiopharmaceuticals onto Plastic Syringes

H. Kvaternik, Jakob Gatterer, Elisabeth Plhak, J. Schwarzgruber, R. Aigner
{"title":"Systematic Assessment of the Adsorption of 99mTc-Radiopharmaceuticals onto Plastic Syringes","authors":"H. Kvaternik, Jakob Gatterer, Elisabeth Plhak, J. Schwarzgruber, R. Aigner","doi":"10.2967/jnmt.119.235432","DOIUrl":null,"url":null,"abstract":"The phenomenon of adsorption of several 99mTc-radiopharmaceuticals onto disposable syringes is common knowledge and can reach a level of up to 50%, with the result being inadequate dosing. The resulting underdosing has a substantial influence on the quality of imaging, especially in pediatric patients. Therefore, we aimed to establish a standardized in vitro assessment to investigate the adsorption of several 99mTc-radiopharmaceuticals on various brands of syringes. Methods: The 99mTc-radiopharmaceuticals were prepared according to manufacturer instructions. For the assessment, the disposable syringes (n = 3) were filled to one third of capacity with the 99mTc preparation and incubated for 30 min at room temperature. The syringes were emptied into evacuated vials, and the radioactivity of the syringes was measured before and after they were emptied. Furthermore, the dilution effect of 99mTc preparations was studied. We used 2 different brands of syringes and systematically examined 99mTc-pertechnetate, 99mTc-butedronate, 99mTc-oxidronate, 99mTc-medronate, 99mTc-tetrofosmin, 99mTc-sestamibi, 99mTc(V)-dimercaptosuccinic acid, and 99mTc-succimer. Additionally, 99mTc-succimer was retested with 5 brands of syringes. Results: 99mTc-pertechnetate, 99mTc-phosphonates, and 99mTc(V)-dimercaptosuccinic acid showed no significant adsorption. The measured radioactive retention of 2%–5% was equivalent to the determined dead volume. Using 99mTc-tetrofosmin, we found a slight but significant adsorption of 4%–7%. The 99mTc-sestamibi preparation showed a nonsignificant retention of 3%–5%. However, when the 99mTc-sestamibi was diluted 1:10 with saline, the adsorption rate increased to 9%–13%. 99mTc-succimer displayed different adsorption levels depending on the brand of syringe and the preparation technique. The adsorption of 99mTc-succimer, prepared from kits according to the instructions, did not exceed 15%. The 1:10 saline dilution of a 99mTc-succimer kit preparation, as well as an in-house preparation, demonstrated a radioactive syringe adsorption rate of more than 30%. Conclusion: The results revealed the significance of syringe adsorption of radiopharmaceuticals in the prevention of underdosing. Therefore, a quality assurance assessment is recommended before the introduction of new brands of plastic syringes or routine application of diluted or in-house radiopharmaceuticals.","PeriodicalId":22799,"journal":{"name":"The Journal of Nuclear Medicine Technology","volume":"71 1","pages":"168 - 173"},"PeriodicalIF":0.0000,"publicationDate":"2019-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Nuclear Medicine Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2967/jnmt.119.235432","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

The phenomenon of adsorption of several 99mTc-radiopharmaceuticals onto disposable syringes is common knowledge and can reach a level of up to 50%, with the result being inadequate dosing. The resulting underdosing has a substantial influence on the quality of imaging, especially in pediatric patients. Therefore, we aimed to establish a standardized in vitro assessment to investigate the adsorption of several 99mTc-radiopharmaceuticals on various brands of syringes. Methods: The 99mTc-radiopharmaceuticals were prepared according to manufacturer instructions. For the assessment, the disposable syringes (n = 3) were filled to one third of capacity with the 99mTc preparation and incubated for 30 min at room temperature. The syringes were emptied into evacuated vials, and the radioactivity of the syringes was measured before and after they were emptied. Furthermore, the dilution effect of 99mTc preparations was studied. We used 2 different brands of syringes and systematically examined 99mTc-pertechnetate, 99mTc-butedronate, 99mTc-oxidronate, 99mTc-medronate, 99mTc-tetrofosmin, 99mTc-sestamibi, 99mTc(V)-dimercaptosuccinic acid, and 99mTc-succimer. Additionally, 99mTc-succimer was retested with 5 brands of syringes. Results: 99mTc-pertechnetate, 99mTc-phosphonates, and 99mTc(V)-dimercaptosuccinic acid showed no significant adsorption. The measured radioactive retention of 2%–5% was equivalent to the determined dead volume. Using 99mTc-tetrofosmin, we found a slight but significant adsorption of 4%–7%. The 99mTc-sestamibi preparation showed a nonsignificant retention of 3%–5%. However, when the 99mTc-sestamibi was diluted 1:10 with saline, the adsorption rate increased to 9%–13%. 99mTc-succimer displayed different adsorption levels depending on the brand of syringe and the preparation technique. The adsorption of 99mTc-succimer, prepared from kits according to the instructions, did not exceed 15%. The 1:10 saline dilution of a 99mTc-succimer kit preparation, as well as an in-house preparation, demonstrated a radioactive syringe adsorption rate of more than 30%. Conclusion: The results revealed the significance of syringe adsorption of radiopharmaceuticals in the prevention of underdosing. Therefore, a quality assurance assessment is recommended before the introduction of new brands of plastic syringes or routine application of diluted or in-house radiopharmaceuticals.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
塑料注射器对99mtc -放射性药物吸附的系统评价
几种99mmc放射性药物吸附在一次性注射器上的现象是众所周知的,可达到高达50%的水平,结果是剂量不足。由此产生的剂量不足对成像质量有实质性影响,特别是在儿科患者中。因此,我们旨在建立一个标准化的体外评估,以研究几种99mtc放射性药物在不同品牌注射器上的吸附。方法:按照生产厂家说明书制备99mtc放射性药物。为了进行评估,将一次性注射器(n = 3)充入99mTc制剂至容量的三分之一,并在室温下孵育30分钟。将注射器倒入抽真空的小瓶中,并在抽空前后测量注射器的放射性。此外,还研究了99mTc制剂的稀释效果。我们使用了2种不同品牌的注射器,系统地检测了99mTc-高技术酸盐、99mTc-丁二酸盐、99mTc-氧化二酸盐、99mTc-甲氧膦酸盐、99mTc-四氟氰胺、99mTc-sestamibi、99mTc(V)-二巯基琥珀酸和99mTc-琥珀酸盐。此外,99mtc -琥珀酸盐在5个品牌的注射器中进行了重新测试。结果:99mTc-高技术酸盐、99mTc-膦酸盐和99mTc(V)-二巯基琥珀酸均无明显吸附作用。测得的放射性滞留量为2% ~ 5%,与测定的死体积相当。使用99mTc-tetrofosmin,我们发现轻微但显著的吸附为4%-7%。99mTc-sestamibi制剂显示3%-5%的不显著保留率。然而,当99mTc-sestamibi用生理盐水1:10稀释时,吸附率增加到9%-13%。99mtc -二聚体的吸附水平随注射器品牌和制备工艺的不同而不同。根据说明书制备的试剂盒对99mtc -二聚体的吸附不超过15%。用1:10的盐水稀释99mtc -琥珀酸盐试剂盒制剂,以及内部制剂,显示放射性注射器吸附率超过30%。结论:注射器吸附放射性药物对预防剂量不足具有重要意义。因此,建议在引进新品牌塑料注射器或常规应用稀释或内部放射性药物之前进行质量保证评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Diuretic Renal Scintigraphy Stability Matters: Radiochemical Stability of Therapeutic Radiopharmaceutical 177Lu-PSMA I&T Small-Bowel and Colon Transit SNMMI Procedure Standard/EANM Practice Guideline for Molecular Breast Imaging with Dedicated γ-Cameras SNMMI Clinical Trials Network Research Series for Technologists: Clinical Research Primer—Regulatory Process, Part II: The Role of the Institutional Review Board in Food and Drug Administration–Regulated Radiopharmaceutical Research
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1